Platinum PB8
Natural health product licensed in Canada
- Other names
- Pro PB8
- Licence holder
- Naka Herbs & Vitamins Ltd.
- NPN or DIN-HM
- 80128987
- Status
- Active licence
- Licence date
- 16 January 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium animalis subsp. lactis Source : Bl-04 | 6.7 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 2.3 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lp-115 | 2.3 Milliards d'UFC | Not calculated |
| Lacticaseibacillus Casei Source : Lc-11 | 1.2 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : GG | 1.5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Phosphate de potassium monobasique, Gomme de gellane, Sucrose, Inuline, Hypromellose, Stéarate de magnésium, Chlorure de sodium, Fructooligosaccharides, Phosphate de dipotassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Reduces the risk of developing upper-respiratory tract illness in physically active adults. Reduces the duration of upper-respiratory tract illness in physically active adults. May increase immune response time following oral vaccination. Promotes favourable gut flora/intestinal microflora. Reduces whole gut transit time/helps to accelerate intestinal transit time. Supports digestion by reducing transit time. Reduces frequency of functional gastrointestinal symptoms (e.g. constipation, irregularity, flatulence). Promotes bowel movement. Helps provide gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80128987
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.